Type 2 diabetes
Vitamin D and type 2 diabetes
This article gives an overview about the intriguing relationship between vitamin D and type 2 diabetes and explores the mechanisms which can potentially confirm the hypothesis of altered vitamin D levels and dysglycaemic status, and whether vitamin D replacement could possibly become a therapeutic strategy in managing people with type 2 diabetes in the future.
New treatments for type 2 diabetes: are we any closer to reducing iatrogenic hypoglycaemia?
The barrier of iatrogenic hypoglycaemia has limited the utility and safety of conventional diabetes medications. Novel agents for type 2 diabetes aim to surmount the impediment of iatrogenic hypoglycaemia and unmask the full realisation and benefits of achieving sustained euglycaemia over a lifetime of diabetes.
Jason Seewoodhary, Stephen Phooi Yew Wong and Kaharanthilaka Poojanie Ekanayake
The role of GLP-1 receptor agonists as weight loss agents in patients with and without type 2 diabetes
Obesity contributes to the pathogenesis of type 2 diabetes (T2DM) and cardiovascular disease. A modest weight loss of 5–10% can have significant impact on glucose control, medications use and patients’ functionality and quality of life.
Shujah Dar, Abd A Tahrani and Milan K Piya